City Of London
Billionaire Peltz Nabs Unilever Board Seat: The London Rush
This article is for subscribers only.
Here’s the key business news from London-listed companies this morning.
GSK Plc: The pharma giant agreed to buy Affinivax Inc, a company developing next-generation experimental vaccines in Boston, Massachusetts, for $2.1 billion upfront and as much as $1.2 billion more in possible milestones.